160 Results

People

  1. Scher
    Scher
  2. Mulhall
    Mulhall
  3. Morris
    Morris
  4. Kelly
    Kelly
  5. Eastham
    Eastham
  6. Flores Martinez
    Flores Martinez
  7. Slovin
    Slovin
  8. Fair
    Fair
  9. Heston
    Heston
  10. Nelson
    Nelson

Groups

  1. Department of Medicine (70)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (50)
  4. Surgery (49)
  5. Urology (43)
  6. Population Sciences Research Program (33)
  7. Survivorship Research (27)
  8. Epidemiology and Biostatistics (18)
  9. Sloan Kettering Institute Faculty (15)
  10. Hematologic Malignancies, Division of (14)
  1. "testosterone"
Formats
  1. Journal Article (150)
  2. Review (5)
  3. Book Section (2)
  4. Correspondence (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (70)
  2. Solid Tumor Oncology Division (63)
  3. Genitourinary Oncology Service (50)
  4. Surgery (49)
  5. Urology (43)
  6. Population Sciences Research Program (33)

More Groups

People
  1. Howard Scher (29)
  2. John Mulhall (27)
  3. Michael Morris (14)
  4. William Kelly (10)
  5. James Eastham (8)
  6. Jose Flores Martinez (8)

More People

Years
  1. 2025 (5)
  2. 2024 (12)
  3. 2023 (4)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (5)

More Years

Publications
  1. Journal of Sexual Medicine (15)
  2. Journal of Clinical Oncology (11)
  3. European Urology (8)
  4. BJU International (7)
  5. Cancer (7)
  6. Urology (7)

More Publications

Publishers
  1. Elsevier Inc. (24)
  2. Elsevier Science, Inc. (24)
  3. Wiley Blackwell (17)
  4. American Society of Clinical Oncology (11)
  5. Oxford University Press (10)
  6. John Wiley & Sons (8)

More Publishers

Results (160)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Baseline testosterone levels in men with clinically localized high-risk prostate cancer treated with radical prostatectomy with or without neoadjuvant chemohormonal therapy (Alliance)
    Journal Article

    Eastham, J. A.; Heller, G.; Hillman, D. W.; Hahn, O. M.; Parsons, J. K.; Mohler, J. L.; Small, E. J.; Morris, M.
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • Prostate-specific antigen nadir and testosterone level at prostate-specific antigen failure following radiation and androgen suppression therapy for unfavorable-risk prostate cancer and the risk of all-cause and prostate cancer–specific mortality
    Journal Article

    Bitterman, D. S.; Chen, M. H.; Wu, J.; Renshaw, A. A.; Loffredo, M.; Kantoff, P. W.; Small, E. J.; D'Amico, A. V.
    Cancer (2021)

    Fulltext@MSK | Save
  • The utilization and impact of aromatase inhibitor therapy in men with elevated estradiol levels on testosterone therapy
    Journal Article

    Punjani, N.; Bernie, H.; Salter, C.; Flores, J.; Benfante, N.; Mulhall, J. P.
    Sexual Medicine (2021)

    Fulltext@MSK | Save
  • Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer
    Journal Article

    Gartrell, B. A.; Roach, M. 3rd; Retter, A.; Sokol, G. H.; Del Priore, G.; Scher, H. I.
    Investigational New Drugs (2021)

    Fulltext@MSK | Save
  • Diagnosis and treatment of infertility in men: AUA/ASRM guideline part II
    Guidelines

    Schlegel, P. N.; Sigman, M.; Collura, B.; De Jonge, C. J.; Eisenberg, M. L.; Lamb, D. J.; Mulhall, J. P.; Niederberger, C.; Sandlow, J. I.; Sokol, R. Z.; more...
    Fertility and Sterility (2021)

    Fulltext@MSK | Save
  • Cardiovascular safety of degarelix versus leuprolide for advanced prostate cancer: The PRONOUNCE trial study design
    Journal Article

    Melloni, C.; Slovin, S. F.; Blemings, A.; Goodman, S. G.; Evans, C. P.; Nilsson, J.; Bhatt, D. L.; Zubovskiy, K.; Olesen, T. K.; Dugi, K.; more...
    JACC: CardioOncology (2020)

    Fulltext@MSK | Save
  • ‘Case of the Month’ from Memorial Sloan Kettering Cancer Center, New York, NY, USA: Managing newly diagnosed metastatic testicular germ cell tumour in a COVID-19-positive patient
    Journal Article

    Almassi, N.; Mulhall, J. P.; Funt, S. A.; Sheinfeld, J.
    BJU International (2020)

    Fulltext@MSK | Save
  • Androgens and overall survival in patients with metastatic castration-resistant prostate cancer treated with docetaxel
    Journal Article

    Ryan, C. J.; Dutta, S.; Kelly, W. K.; Middleberg, R.; Russell, C.; Morris, M. J.; Taplin, M. E.; Halabi, S.; the Alliance for Clinical Trials in Oncology Genitourinary Committee
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Extended survival after surgical resection for pituitary metastases: Clinical features, management, and outcomes of metastatic disease to the sella
    Journal Article

    Patel, K. R.; Zheng, J.; Tabar, V.; Cohen, M. A.; Girotra, M.
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Androgen decline and survival during docetaxel therapy in metastatic castration resistant prostate cancer (mCRPC)
    Journal Article

    Ryan, C. J.; Dutta, S.; Kelly, W. K.; Russell, C.; Small, E. J.; Morris, M. J.; Taplin, M. E.; Halabi, S.; From The Alliance for Clinical Trials in Oncology Genitourinary Committee
    Prostate Cancer and Prostatic Diseases (2020)

    Fulltext@MSK | Save